FDA Warns Novo Nordisk Over Unreported Ozempic Safety Incidents

Plainsboro, Wednesday, 11 March 2026.
The FDA warned Novo Nordisk over systemic failures to report severe Ozempic side effects, including three patient deaths, highlighting intensified regulatory scrutiny on the lucrative weight-loss market.